Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study

Clinical trial NCT03733249 · TERMINATED

Trial details

NCT number: NCT03733249
Sponsor: Bellicum Pharmaceuticals
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Leukemia, Acute Myeloid (AML), Child Lymphoma, Non-Hodgkin Myelodysplastic Syndromes Primary Immunodeficiency Anemia, Aplastic Hemoglobinopathies Cytopenia Fanconi Anemia Diamond Blackfan Anemia Thalassemia Anemia, Sickle Cell

Start date: 2017-01-01
Primary completion: 2020-06-30
Enrollment: 187

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.